BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37250648)

  • 1. Efficacy and prognostic factors of repeated hepatectomy for postoperative intrahepatic recurrence of hepatocellular carcinoma undergoing initial hepatectomy.
    Cen F; Sun X; Pan Z; Yan Q
    Front Med (Lausanne); 2023; 10():1127122. PubMed ID: 37250648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.
    Umeda Y; Matsuda H; Sadamori H; Matsukawa H; Yagi T; Fujiwara T
    World J Surg; 2011 Jan; 35(1):170-7. PubMed ID: 20922387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.
    Chan AC; Poon RT; Cheung TT; Chok KS; Chan SC; Fan ST; Lo CM
    World J Surg; 2012 Jan; 36(1):151-6. PubMed ID: 22030561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat hepatectomy versus radiofrequency ablation in management of recurrent hepatocellular carcinoma: an average treatment effect analysis.
    Chua DW; Koh YX; Syn NL; Chuan TY; Yao TJ; Lee SY; Goh BKP; Cheow PC; Chung AY; Chan CY
    Ann Surg Oncol; 2021 Nov; 28(12):7731-7740. PubMed ID: 33969464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy and prognostic risk factors of salvage liver transplantation, rehepatectomy, and local ablation in the treatment of postoperative recurrence of hepatocellular carcinoma].
    Lin P; You YK; Liu JY; Yang F; Cai QC; Jiang Y; Shen JJ
    Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):155-160. PubMed ID: 37137830
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
    Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
    Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat hepatic resection combined with intraoperative radiofrequency ablation versus repeat hepatic resection alone for recurrent and multiple hepatocellular carcinoma patients meeting the Barcelona Clinic Liver Cancer stage A: A propensity score-matched analysis.
    Huang Y; Xu L; Huang M; Jiang L; Xu M
    Cancer Med; 2023 Apr; 12(8):9213-9227. PubMed ID: 36722129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure laparoscopic liver resection versus percutaneous radiofrequency ablation for small hepatocellular carcinoma: a propensity score and multivariate analysis.
    Cheng KC; Ho KM
    Transl Cancer Res; 2022 Jan; 11(1):43-51. PubMed ID: 35261883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy.
    Wei MC; Zhang YJ; Chen MS; Chen Y; Lau WY; Peng ZW
    Front Oncol; 2022; 12():868429. PubMed ID: 35814378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 14. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
    Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
    Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yen YH; Li WF; Wang CC; Lu SN; Kee KM; Yong CC; Cheng YF; Wang JH; Hu TH; Hung CH; Chen CH
    Surg Oncol; 2022 Jun; 42():101769. PubMed ID: 35468499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.
    Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.